Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Hutchison China MediTech Limited    HCM   KYG4672N1016

HUTCHISON CHINA MEDITECH LIMITED (HCM)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
07/12/2018 07/13/2018 07/16/2018 07/17/2018 07/18/2018 Date
4750(c) 4740(c) 4660(c) 4735(c) 4835(c) Last
25 471 1 968 3 509 6 498 7 294 Volume
+6.15% -0.21% -1.69% +1.61% +2.11% Change
More quotes
Financials (USD)
Sales 2018 166 M
EBIT 2018 -69,0 M
Net income 2018 -39,0 M
Finance 2018 262 M
Yield 2018 -
Sales 2019 188 M
EBIT 2019 -86,1 M
Net income 2019 -55,5 M
Finance 2019 161 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 23,6x
EV / Sales2019 21,3x
Capitalization 4 169 M
More Financials
Company
Hutchison China MediTech Ltd. is a holding company, which engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products.It operates through the Innovation Platform and Commercial Platform segments.The Innovation Platform segment relates to... 
Sector
Pharmaceuticals
Calendar
07/27 | 08:00amEarnings Release
More about the company
Surperformance© ratings of Hutchison China MediTech L
Trading Rating : - Investor Rating :
More Ratings
Latest news on HUTCHISON CHINA MEDITECH L
06/29HUTCHISON CHINA MEDITECH : Blocklisting Six Monthly Return
PU
06/29HUTCHISON CHINA MEDITECH : Chi-Med to Announce 2018 Half-Year Financial Results
AQ
06/26JAMA : Fruquintinib vs Placebo in Metastatic Colorectal Cancer
PU
06/07HUTCHISON CHINA MEDITECH : Grant of Share Options under Share Option Scheme
PU
06/04HUTCHISON CHINA MEDITECH : Chi-Med Presents Further Fruquintinib FRESCO Trial Da..
AQ
06/01HUTCHISON CHINA MEDITECH LIMITED : Edison issues ADR outlook on Hutchison China ..
AC
05/24HUTCHISON CHINA MEDITECH : Pivotal closes China fund at $150M
AQ
05/11HUTCHISON CHINA MEDITECH : Chi-Med to Present at Bank of America Merrill Lynch A..
AQ
05/07HKEX forms biotech application advisory panel
AQ
04/27HUTCHISON CHINA MEDITECH : Results of AGM Meeting
PU
More news
Sector news : Alternative Medicine
07/18Novartis hints at 2018 outlook hike despite drug price freeze
RE
07/18Novartis hints at 2018 outlook hike despite drug price freeze
RE
07/18NOVARTIS : FDA Expands Approval of Novartis Breast Cancer Drug
DJ
07/18ABBOTT LABORATORIES : on Track for All-Time High After 2Q Earnings -- Data Talk
DJ
07/18NOVARTIS : to Refrain From Rising U.S. Drug Prices -- 3rd Update
DJ
More sector news : Alternative Medicine
Latest Tweets
07/17#MeToo Vs. Music: What Fan Reaction to Simon Le Bon’s Alleged Groping Says Ab..
5
07/16“When Johnson returned here after leaving the White House, he drank, smoked, ..
2
07/15Simon to team: “It’s really challenging on the restart with how slick the tra..
6
07/14Judge orders MN Secretary of State Steve Simon to make voter records public
1
07/14Judge orders MN Secretary of State Steve Simon to make voter records public  
More tweets
Qtime:437
News from SeekingAlpha
03/12Hutchison China MediTech's (HCM) CEO Christian Hogg on Q4 2017 Results - Earn.. 
03/12Hutchison China Meditech FY2017 revenues up 12%; updates guidance 
03/12Hutchison China Meditech  reports FY results 
03/12JF'S CORE BIOTECH BUYS EDITION 1 VOL : Buying Weakness In 2 Beaten Down Stocks 
03/11WEEK IN REVIEW : China Pharma Deals Top $1.5 Billion For Week 
Chart HUTCHISON CHINA MEDITECH L
Duration : Period :
Hutchison China MediTech L Technical Analysis Chart | HCM | KYG4672N1016 | 4-Traders
Technical analysis trends HUTCHISON CHINA MEDITECH L
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 53,9 $
Spread / Average Target -13%
EPS Revisions
Managers
NameTitle
Christian Hogg Chief Executive Officer & Executive Director
Chi Keung To Chairman
Chig Fung Cheng Chief Financial Officer & Executive Director
Wei Guo Su Executive Director, Chief Scientific Officer & EVP
Edith Shih Secretary & Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
HUTCHISON CHINA MEDITECH LIMITED-13.66%4 169
BEIJING TONGRENTANG CO., LTD.10.89%7 306
CANOPY GROWTH CORP17.01%5 683
DONG-E-E-JIAO CO LTD--.--%5 200
MEDRELEAF CORP29.47%2 259
TIANJIN ZHONGXIN PHRMCTL GP CP LTD40.62%1 998